134 related articles for article (PubMed ID: 29895155)
1. USP15 inhibits HPV16 E6 degradation and catalytically inactive USP15 has reduced inhibitory activity.
Yaginuma Y; Yoshimoto M; Tokuda A
Acta Virol; 2018; 62(2):147-156. PubMed ID: 29895155
[TBL] [Abstract][Full Text] [Related]
2. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability.
Vos RM; Altreuter J; White EA; Howley PM
J Virol; 2009 Sep; 83(17):8885-92. PubMed ID: 19553310
[TBL] [Abstract][Full Text] [Related]
4. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
6. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
7. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events.
Xu J; Fang Y; Qin J; Chen X; Liang X; Xie X; Lu W
FEBS Lett; 2016 Dec; 590(24):4594-4605. PubMed ID: 27859058
[TBL] [Abstract][Full Text] [Related]
8. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
[TBL] [Abstract][Full Text] [Related]
10. The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.
Manzo-Merino J; Massimi P; Lizano M; Banks L
Virology; 2014 Feb; 450-451():146-52. PubMed ID: 24503077
[TBL] [Abstract][Full Text] [Related]
11. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
12. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
13. Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women.
Hadami K; Saby C; Dakka N; Collin G; Attaleb M; Khyatti M; Filali-Maltouf A; Morjani H; El Mzibri M
Gene; 2021 Jul; 791():145709. PubMed ID: 33984442
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles.
Harden ME; Munger K
Virology; 2017 Aug; 508():63-69. PubMed ID: 28500882
[TBL] [Abstract][Full Text] [Related]
15. High risk HPV E6 oncoproteins impair the subcellular distribution of the four and a half LIM-only protein 2 (FHL2).
Manzo-Merino J; Massimi P; Banks L; Lizano M
Virology; 2015 Feb; 476():100-105. PubMed ID: 25540819
[TBL] [Abstract][Full Text] [Related]
16. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
Poirson J; Suarez IP; Straub ML; Cousido-Siah A; Peixoto P; Hervouet E; Foster A; Mitschler A; Mukobo N; Chebaro Y; Garcin D; Recberlik S; Gaiddon C; Altschuh D; Nominé Y; Podjarny A; Trave G; Masson M
J Virol; 2022 May; 96(10):e0187521. PubMed ID: 35475668
[TBL] [Abstract][Full Text] [Related]
17. The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases.
Chou CK; Chang YT; Korinek M; Chen YT; Yang YT; Leu S; Lin IL; Tang CJ; Chiu CC
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245560
[TBL] [Abstract][Full Text] [Related]
18. The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers.
Kiran S; Dar A; Singh SK; Lee KY; Dutta A
Mol Cell; 2018 Dec; 72(5):823-835.e5. PubMed ID: 30415951
[TBL] [Abstract][Full Text] [Related]
19. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin ligase E6AP mediates nonproteolytic polyubiquitylation of β-catenin independent of the E6 oncoprotein.
Kuslansky Y; Sominsky S; Jackman A; Gamell C; Monahan BJ; Haupt Y; Rosin-Arbesfeld R; Sherman L
J Gen Virol; 2016 Dec; 97(12):3313-3330. PubMed ID: 27902311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]